Your weekly issue is 1
now FREE on iPad
Essential clinical info by medical professionals
BONUS FEATURES exclusive to iPad
Heavy drinking curbed by smoking cessation drug
ARENICLINE for smoking cessation may reduce alcohol consumption in heavy-drinking smokers, a study shows.
US researchers recruited social drinkers through online classifieds, giving half the group varenicline (Champix, Pfizer) and the other half a placebo. Their drinking and smoking behaviours were monitored for 16 weeks.
Individuals on varenicline reduced alcohol consumption by 36%, but there was no correlation between the number of drinks consumed weekly and the number of cigarettes they smoked, indicating the drug’s effect on drinking behaviour was separate from its effects on smoking.
Psychopharmacology 2012; online 1 May
Tags: , Medical News